Eight years is a long time in medicine. Long enough to sequence a genome, develop an mRNA vaccine, or, in theory, transform how the field thinks about the window before conception. Whether preconception health has earned that transformation is, at best, a complicated answer.

The 2018 Lancet Series on preconception health, led by Judith Stephenson, put forward a case that had been building quietly in reproductive medicine for years: that the health and nutritional status of both men and women before conception carries consequences not merely for pregnancy outcomes, but for the lifelong health trajectories of children. That argument was not universally new, but the Series gave it structure, scale, and a platform that the field had been lacking.

The call was specific. A three-pronged framework, addressing the biological, individual, and public health dimensions of preconception care, anchored in a life course view of health. Not prepregnancy care for women. Preconception health for everyone.

---

What the field has achieved since 2018 is real, if partial. The Series did succeed in broadening the conceptual boundaries of preconception health. Where clinical guidance once trained nearly all its attention on women preparing for pregnancy, the conversation has shifted, meaningfully, to encompass men, couples, and the shared biological terrain both partners bring to conception. That’s progress worth naming.

But naming it is not the same as implementing it. The three-pronged framework Stephenson’s team proposed has not been adopted systematically in most health systems. Biological knowledge about paternal health contributions, while growing, has not translated into routine clinical practice. Individual-level interventions, such as preconception counseling for people with chronic conditions, remain inconsistent and poorly resourced. And public health infrastructure capable of supporting population-level preconception health is, in most countries, essentially absent.

Not solved. Not even close.

---

The biological case is worth reviewing because it underpins everything else. Preconception health encompasses the range of interventions and health states that influence gamete quality, implantation, placental function, and fetal development before a pregnancy is recognized. Decades of research have established that maternal nutritional status, particularly folate, iodine, and iron, affects embryogenesis at stages occurring before most women know they are pregnant. The 2018 Series extended that frame to include paternal factors, among them sperm DNA integrity, obesity, alcohol use, and occupational exposures, as contributors to conception success and offspring health.

Epigenetic mechanisms sit at the center of this conversation. Evidence from animal and human observational studies indicates that paternal diet and metabolic status can influence gene expression in offspring through sperm epigenomes, independently of genetic sequence. This is not fringe science. The mechanisms are plausible, the animal data are robust, and the human data, while largely observational rather than from randomized controlled trials (RCTs), are accumulating in a consistent direction.

Still, the observational design of most human studies on paternal preconception exposures limits causal inference. Confounding by socioeconomic status, shared household environment, and maternal health behaviors remains difficult to disentangle. Until adequately powered RCTs or natural experiment designs address this gap, the evidence base for paternal preconception interventions will remain inferential. That’s an honest limitation. It does not, however, eliminate the clinical relevance of existing findings. It simply argues for caution in how strongly clinicians frame recommendations to male patients.

---

The individual-level dimension is where preconception health most visibly fails to reach its intended audience. The core problem is access and timing. Preconception care, to be effective, must reach individuals before conception is being actively attempted, ideally years before, during the period when health behaviors and chronic disease management can most plausibly shift biological trajectories. Current health systems are largely reactive. A woman schedules a first antenatal appointment after a positive test, by which point organogenesis is already underway. A man may never receive any reproductive health guidance outside of a fertility clinic.

Contraception services, primary care visits, and opportunistic health encounters represent the most realistic contact points for preconception counseling in the general population. The evidence supporting structured preconception counseling delivered through primary care is modest, drawn largely from observational studies and service evaluations rather than RCTs with clinical endpoints. What does exist suggests that when counseling is delivered, it can shift folic acid supplementation rates, improve management of preexisting conditions such as type 2 diabetes and epilepsy, and increase health literacy around reproductive planning. Those outcomes are clinically consequential even if they are not yet quantified in terms of downstream pregnancy or offspring health.

The infrastructure problem, though, doesn’t resolve itself through better counseling alone. Many individuals who could benefit from preconception guidance don’t have stable access to primary care. That’s particularly true in low- and middle-income countries, where preconception health intersects acutely with undernutrition, adolescent pregnancy, and limited contraceptive access. It’s also true in high-income settings characterized by fragmented care delivery and persistent health inequities.

---

Public health is the third dimension and, candidly, the least developed of the three. A genuine population-level approach to preconception health would require integrating reproductive life planning into adolescent health programs, occupational health frameworks, food policy, and environmental regulation. It would require treating the preconception period not as a clinical niche but as a public health priority deserving of coordinated investment.

That has not happened at scale. Individual countries have made incremental moves. Folic acid fortification of staple foods remains one of the most evidence-based public health interventions for neural tube defect prevention, and the number of countries implementing mandatory fortification has grown since 2018. Iodine fortification programs have expanded. But these are targeted nutritional interventions, not the coordinated preconception health strategy the 2018 Series called for.

The political economy of preconception public health is genuinely difficult. Preconception health competes with visible, measurable, near-term health priorities for government attention and funding. Its benefits are probabilistic, distributed across a generation, and difficult to attribute clearly to any specific intervention. That makes it structurally resistant to the short policy cycles in which most health ministries operate.

---

A related point merits attention. The framing of preconception health around future children’s health, while scientifically sound and motivationally resonant, carries risks. Instrumentalizing the health of adults primarily as a means of optimizing offspring outcomes raises ethical tensions, particularly for women, who have historically borne a disproportionate burden of reproductive health responsibility. The 2018 Series was attentive to this concern, and the extension of preconception health to include men and couples was partly a corrective response to the field’s prior narrow focus on women. That corrective is necessary and should continue to shape how clinicians and public health practitioners communicate about preconception risk.

The Lancet editorial reviewing this eight-year retrospective notes that the Series helped to broaden the concept of preconception health in ways that the field has, at least partially, absorbed. That is not nothing. Conceptual shifts in medicine are slow and often underappreciated. The move from a woman-centered to a couple-centered and ultimately a population-centered model of preconception health represents a substantive change in how reproductive medicine frames its responsibilities.

---

What the next phase requires is less about conceptual innovation and more about implementation science. The field now has a reasonably clear picture of what preconception health should encompass, which populations are underserved, and which biological mechanisms are plausible targets for intervention. What it lacks is the clinical and public health infrastructure to deliver those interventions at scale.

Several priorities stand out. First, primary care systems need structured preconception health pathways, ideally ones that integrate with contraception services and chronic disease management rather than operating as a separate clinical silo. Second, male reproductive health must be incorporated into routine clinical guidance, with the same seriousness that maternal preconception health has received. Third, food fortification programs warrant continued expansion and evaluation, given the strength of evidence for nutritional interventions. And fourth, observational evidence on paternal epigenetic contributions should drive investment in adequately powered RCTs, not premature clinical mandates.

Eight years on from Stephenson’s call, the honest assessment is this: the field understands the problem better than it did. The evidence base has grown. The conceptual frame has widened. But health systems have not yet caught up. The distance between what is known and what is delivered remains considerable, and closing that gap is the task that now belongs to clinicians, public health practitioners, and policymakers in equal measure.